{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:44:36Z","timestamp":1773236676620,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,3,24]],"date-time":"2012-03-24T00:00:00Z","timestamp":1332547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s10147-012-0402-z","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T15:28:31Z","timestamp":1332516511000},"page":"454-463","source":"Crossref","is-referenced-by-count":11,"title":["Clinical significance of KRAS gene mutation and epidermal growth factor receptor expression in Japanese patients with squamous cell carcinoma of the larynx, oropharynx and hypopharynx"],"prefix":"10.1007","volume":"18","author":[{"given":"Satoshi","family":"Fujii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideoki","family":"Uryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kensuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,24]]},"reference":[{"key":"402_CR1","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","volume":"127","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008. GLOBOCAN 2008. Int J Cancer 127:2893\u20132917","journal-title":"Int J Cancer"},{"key":"402_CR2","unstructured":"Diaz Jr EM, Sturges EM, Laramore GE (2003) Neoplasms of the head and neck. Holland JF, Frei E (eds) Cancer Medicine. BC Decker Inc., London, pp 1325\u20131371"},{"key":"402_CR3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejca.2009.12.014","volume":"46","author":"J Ferlay","year":"2010","unstructured":"Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46:765\u2013781","journal-title":"Eur J Cancer"},{"key":"402_CR4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jjco\/hyq169","volume":"41","author":"T Matsuda","year":"2011","unstructured":"Matsuda T, Marugame T, Kamo KI et al (2011) The Japan Cancer Surveillance Research Group. Cancer incidence and incidence rates in Japan in 2005: Based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project. Jpn J Clin Oncol 41:139\u2013147","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"402_CR5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/jjco\/hyh056","volume":"34","author":"The Research Group for Population-based Cancer Registration in Japan","year":"2004","unstructured":"The Research Group for Population-based Cancer Registration in Japan (2004) Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol 34(6):352","journal-title":"Jpn J Clin Oncol"},{"key":"402_CR6","volume-title":"Cancer statistics morbidity\/death\/prognosis 2004","author":"A Ohshima","year":"2004","unstructured":"Ohshima A et al (2004) Cancer statistics morbidity\/death\/prognosis 2004. Shinohara Shuppan Shinsha, Tokyo"},{"key":"402_CR7","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2201::AID-CNCR20>3.0.CO;2-7","volume":"83","author":"H Iro","year":"1998","unstructured":"Iro H, Waldfahrer F (1998) Evaluation of the newly updated TNM classification of head and neck carcinoma with data from 3247 patients. Cancer 83:2201\u20132207","journal-title":"Cancer"},{"key":"402_CR8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJM199301213280306","volume":"328","author":"E Vokes","year":"1993","unstructured":"Vokes E, Weichselbaum R, Lippman S et al (1993) Head and neck cancer. New Engl J Med 328:184\u2013194","journal-title":"New Engl J Med"},{"key":"402_CR9","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1078-0432.CCR-03-1077","volume":"10","author":"A Argiris","year":"2004","unstructured":"Argiris A, Bruce E (2004) Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemotherapy. Clin Cancer Res 10:1956\u20131962","journal-title":"Clin Cancer Res"},{"issue":"7","key":"402_CR10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1517\/14712598.2011.582464","volume":"11","author":"CR Garrett","year":"2011","unstructured":"Garrett CR, Eng C (2011) Cetuximab in the treatment of patients with colorectal cancer. Expert Opin Biol Ther 11(7):937\u2013949","journal-title":"Expert Opin Biol Ther"},{"issue":"20","key":"402_CR11","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1056\/NEJMoa071834","volume":"357","author":"DJ Jonker","year":"2007","unstructured":"Jonker DJ, O\u2019Callaghan CJ, Karapetis CS et al (2007) Cetuximab for the treatment of colorectal cancer. N Engl J Med 357(20):2040\u20132048","journal-title":"N Engl J Med"},{"issue":"17","key":"402_CR12","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","volume":"359","author":"CS Karapetis","year":"2008","unstructured":"Karapetis CS, Khambata-Ford S, Jonker DJ et al (2008) K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 359(17):1757\u20131765","journal-title":"N Engl J Med"},{"key":"402_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0303-7207(83)90027-8","volume":"31","author":"G Carpenter","year":"1983","unstructured":"Carpenter G (1983) The biochemistry and physiology of the receptor-kinase for epidermal growth factor. Mol Cell Endocrinol 31:1\u201319","journal-title":"Mol Cell Endocrinol"},{"key":"402_CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/1040-8428(94)00144-I","volume":"19","author":"DS Salomon","year":"1995","unstructured":"Salomon DS, Brandt R, Ciardiello F et al (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19:183\u2013232","journal-title":"Crit Rev Oncol Hematol"},{"key":"402_CR15","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1200\/JCO.2003.01.504","volume":"21","author":"J Mendelsohn","year":"2003","unstructured":"Mendelsohn J, Baselga J (2003) Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer. J Clin Oncol 21:2787\u20132799","journal-title":"J Clin Oncol"},{"issue":"4","key":"402_CR16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1053\/j.seminoncol.2006.04.003","volume":"33","author":"J Mendelsohn","year":"2006","unstructured":"Mendelsohn J, Baselga J (2006) Epidermal growth factor receptor targeting in cancer. Semin Oncol 33(4):369\u2013385","journal-title":"Semin Oncol"},{"issue":"1","key":"402_CR17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.seminoncol.2004.09.036","volume":"32","author":"AC Lockhart","year":"2005","unstructured":"Lockhart AC, Berlin JD (2005) The epidermal growth factor receptor as a target for colorectal cancer therapy. Semin Oncol 32(1):52\u201360","journal-title":"Semin Oncol"},{"issue":"12","key":"402_CR18","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/bjs.1800771211","volume":"77","author":"RJ Steele","year":"1990","unstructured":"Steele RJ, Kelly P, Ellul B et al (1990) Epidermal growth factor receptor expression in colorectal cancer. Br J Surg 77(12):1352\u20131354","journal-title":"Br J Surg"},{"issue":"1","key":"402_CR19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0960-7404(92)90062-P","volume":"1","author":"AM Kluftinger","year":"1992","unstructured":"Kluftinger AM, Robinson BW, Quenville NF et al (1992) Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancer. Surg Oncol 1(1):97\u2013105","journal-title":"Surg Oncol"},{"key":"402_CR20","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1200\/JCO.2006.07.2587","volume":"24","author":"CH Chung","year":"2006","unstructured":"Chung CH, Ely K, McGavran L et al (2006) Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas. J Clin Oncol 24:4170\u20134176","journal-title":"J Clin Oncol"},{"issue":"4","key":"402_CR21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1056\/NEJMoa033025","volume":"351","author":"D Cunningham","year":"2004","unstructured":"Cunningham D, Humblet Y, Siena S et al (2004) Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 351(4):337\u2013345","journal-title":"N Engl J Med"},{"issue":"8","key":"402_CR22","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1349-7006.2008.00861.x","volume":"99","author":"MA Sheikh Ali","year":"2008","unstructured":"Sheikh Ali MA, Gunduz M, Nagatsuka H et al (2008) Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma. Cancer Sci 99(8):1589\u20131594","journal-title":"Cancer Sci"},{"issue":"7","key":"402_CR23","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1369\/jhc.3A6195.2004","volume":"52","author":"CS Karapetis","year":"2004","unstructured":"Karapetis CS, Khambata-Ford S, Jonker DJ et al (2004) K-ras mutations and benefit from cetuximab in advanced colorectal cancer. J Histochem Cytochem 52(7):893\u2013901","journal-title":"J Histochem Cytochem"},{"issue":"7","key":"402_CR24","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1369\/jhc.3A6195.2004","volume":"52","author":"D Atkins","year":"2008","unstructured":"Atkins D, Reiffen KA, Tegtmeier CL et al (2008) Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections. J Histochem Cytochem 52(7):893\u2013901","journal-title":"J Histochem Cytochem"},{"key":"402_CR25","unstructured":"Japanese Society of Medical Oncology (2009) Clinical oncology update-essentials for medical oncologists, 2nd edn. Nankodo, Tokyo"},{"issue":"1","key":"402_CR26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-154-1-201101040-00006","volume":"154","author":"IJ Dahabreh","year":"2011","unstructured":"Dahabreh IJ, Terasawa T, Castaldi PJ et al (2011) Systematic review: anti-epidermal growth factor receptor treatment effect. Ann Intern Med 154(1):37\u201349","journal-title":"Ann Intern Med"},{"issue":"30","key":"402_CR27","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1038\/sj.onc.1206705","volume":"22","author":"A Weber","year":"2003","unstructured":"Weber A, Langhanki L, Sommerer F et al (2003) Mutations of the BRAF gene in squamous cell carcinoma of the head and neck. Oncogene 22(30):4757\u20134759","journal-title":"Oncogene"},{"key":"402_CR28","first-page":"189","volume":"10","author":"N Damme Van","year":"2010","unstructured":"Van Damme N, Deron P, Van Roy N et al (2010) Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas 10:189","journal-title":"Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas"},{"issue":"4","key":"402_CR29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5981\/jjhnc.36.436","volume":"36","author":"T Hama","year":"2010","unstructured":"Hama T, Kato T (2010) Molecular targeted therapy for EGFR and VEGF in head and neck squamous cell carcinomas. Toukeibu-Gan 36(4):436\u2013441","journal-title":"Toukeibu-Gan"},{"key":"402_CR30","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1186\/1471-2407-9-303","volume":"9","author":"M Scartozzi","year":"2009","unstructured":"Scartozzi M, Bearzi I, Mandolesi A et al (2009) Epidermal growth factor receptor (EGFR) gene copy number (GCN) correlates with clinical activity of irinotecan-cetuximab in K-RAS wild-type colorectal cancer: a fluorescence in situ (FISH) and chromogenic in situ hybridization (CISH) analysis. BMC Cancer 9:303","journal-title":"BMC Cancer"},{"issue":"6","key":"402_CR31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.oraloncology.2011.03.020","volume":"47","author":"B Szab\u00f3","year":"2011","unstructured":"Szab\u00f3 B, Nelh\u0171bel GA, K\u00e1rp\u00e1ti A et al (2011) Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas. Oral Oncol 47(6):487\u2013496","journal-title":"Oral Oncol"},{"issue":"10","key":"402_CR32","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/hed.21365","volume":"32","author":"ME Sharafinski","year":"2010","unstructured":"Sharafinski ME, Ferris RL, Ferrone S et al (2010) Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck. Head Neck 32(10):1412\u20131421","journal-title":"Head Neck"},{"issue":"24","key":"402_CR33","first-page":"7350","volume":"62","author":"KK Ang","year":"2002","unstructured":"Ang KK, Berkey BA, Tu X et al (2002) Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62(24):7350\u20137356","journal-title":"Cancer Res"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-012-0402-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-012-0402-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-012-0402-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T00:49:38Z","timestamp":1561510178000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-012-0402-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3,24]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["402"],"URL":"https:\/\/doi.org\/10.1007\/s10147-012-0402-z","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,24]]}}}